Galectin-3 captures ongoing myocardial fibrosis and structural remodeling, offering particularly strong prognostic information in HFpEF compared to HFrEF.<h4>Conclusion</h4>Collectively, these biomarkers represent complementary windows into the pathophysiology of HFpEF. The gene discussed is LGALS3; the disease is Myocardial fibrosis.